Recent case–control genome-wide association studies have identified some CHD risks loci located within a so-called ‘CHD critical region’ on chromosome 21, one mapping near RIPK4 and the second one including ZBTB21 [48]. This evidence concerns the gene RIPK4 and coronary artery disorder.